The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical Trial
Abstract
One hundred eighty‐nine patients with rheumatoid arthritis were entered into a prospective, controlled, double‐blind multicenter trial comparing placebo and methotrexate (MTX). One hundred ten patients completed 18 weeks of therapy. No remissions were seen, but patients able to tolerate low‐dose pulse MTX therapy were significantly improved, compared with patients receiving placebo therapy, for all clinical variables measured, including joint pain/tenderness and swelling counts, rheumatoid nodules, and patient and physician assessment of disease activity. MTX treatment demonstrated statistically significant improvement over placebo in patients with anemia, elevated erythrocyte sedimentation rate, and rheumatoid factor. However, nearly one‐third of the patients receiving MTX were withdrawn for adverse drug reactions, of which elevated levels of liver enzymes was the most common. Pancytopenia occurred in 2 patients taking MTX. All adverse drug effects resolved without sequelae. MTX appears to be effective in the treatment of active rheumatoid arthritis but requires close monitoring for toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practical Nonparametric Statistics
Groggel, D. J. (2000) · Technometrics · doi:10.1080/00401706.2000.10486067 · Cited by 11,041
Applied Nonparametric Statistics
Wozniak, P. J., & Daniel, W. W. (1991) · Technometrics · doi:10.2307/1268795 · Cited by 4,987
THERAPEUTIC CRITERIA IN RHEUMATOID ARTHRITIS
STEINBROCKER, O. (1949) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1949.02900430001001 · Cited by 2,877
revision of diagnostic criteria for rheumatoid arthritis
(2001) · Classic Papers in Rheumatology · doi:10.3109/9780203214237-47 · Cited by 2,237
1958 Revision of diagnostic criteria for rheumatoid arthritis
Ropes, M. W., Bennett, G. A., Cobb, S., Jacox, R., & Jessar, R. A. (1959) · Arthritis & Rheumatism · doi:10.1002/1529-0131(195902)2:1<16::aid-art1780020104>3.0.co;2-9 · Cited by 1,999
Sharp, G. C., Irvin, W. S., Tan, E. M., Gould, R. G., & Holman, H. R. (1972) · The American Journal of Medicine · doi:10.1016/0002-9343(72)90064-2 · Cited by 1,835
Preliminary criteria for clinical remission in rheumatoid arthritis
Pinals, R. S., Masi, A. T., & Larsen, R. A. (1981) · Arthritis & Rheumatism · doi:10.1002/art.1780241012 · Cited by 803
The Pharmacology and Clinical Use of Methotrexate
Jolivet, J., Cowan, K. H., Curt, G. A., Clendeninn, N. J., & Chabner, B. A. (1983) · New England Journal of Medicine · doi:10.1056/nejm198311033091805 · Cited by 786
1958 Revision of Diagnostic Criteria for Rheumatoid Arthritis
Ropes, M. W., Bennett, G. A., Cobb, S., Jacox, R., & Jessar, R. A. (1959) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-195941040-00023 · Cited by 515
GUBNER, R. S., August, S., & Ginsberg, V. (1951) · PubMed · Cited by 343
Cited by
Wegener Granulomatosis: An Analysis of 158 Patients
Hoffman, G. S., Kerr, G. S., Leavitt, R. Y., Hallahan, C. W., Lebovics, R. S., Travis, W. D., Rottem, M., & Fauci, A. S. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-6-488 · Cited by 2,857
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L. M., Lightfoot, R., Paulus, H., Strand, V., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380602 · Cited by 2,829
Guidelines for the management of rheumatoid arthritis: 2002 Update
American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002) · Arthritis & Rheumatism · doi:10.1002/art.10148 · Cited by 1,185
Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and Methotrexate
Strand, V. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.21.2542 · Cited by 754
Methotrexate and its mechanisms of action in inflammatory arthritis
Cronstein, B. N., & Aune, T. M. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0373-9 · Cited by 677
Methotrexate for Rheumatoid Arthritis
Kremer, J. M., Alarcón, G. S., Lightfoot, R. W., Willkens, R. F., Furst, D. E., Williams, H. J., Dent, P. B., & Weinblatt, M. E. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370304 · Cited by 607
Self-citationTherapeutic Strategies for Rheumatoid Arthritis
O'Dell, J. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040226 · Cited by 588
Giannini, E. H., Brewer, E. J., Kuzmina, N., Shaikov, A., Maximov, A., Vorontsov, I., Fink, C. W., Newman, A. J., Cassidy, J. T., & Zemel, L. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204163261602 · Cited by 588
Comparative responsiveness of generic and specific quality-of-life instruments
Wiebe, S., Guyatt, G., Weaver, B., Matijevic, S., & Sidwell, C. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00537-1 · Cited by 573
Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review
Wang, W., Zhou, H., & Liu, L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.027 · Cited by 562
Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis
Cronstein, B. N. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.3 · Cited by 535
Factors predicting response to treatment in rheumatoid arthritis: The importance of disease duration
Anderson, J. J., Wells, G., Verhoeven, A. C., & Felson, D. T. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<22::aid-anr4>3.0.co;2-9 · Cited by 503
Kozarek, R. A., Patterson, D. J., Gelfand, M. D., Botoman, V. A., Ball, T. J., & Wilske, K. R. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-5-353 · Cited by 488
Felson, D. T., Anderson, J. J., & Meenan, R. F. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780331001 · Cited by 470
Genestier, L., Paillot, R., Fournel, S., Ferraro, C., Miossec, P., & Revillard, J. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2676 · Cited by 459
Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis
CUTOLO, M., SULLI, A., PIZZORNI, C., SERIOLO, B., & STRAUB, R. H. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.8.729 · Cited by 433
Mechanisms of action of methotrexate
Genestier, L., Paillot, R., Quemeneur, L., Izeradjene, K., & Revillard, J.-P. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00189-2 · Cited by 424
Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers
Brown, P. M., Pratt, A. G., & Isaacs, J. D. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.175 · Cited by 382
The safety and efficacy of the use of methotrexate in long‐term therapy for rheumatoid arthritis
Kremer, J. M., & Lee, J. K. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290702 · Cited by 360
Westlake, S. L., Colebatch, A. N., Baird, J., Kiely, P., Quinn, M., Choy, E., Ostor, A. J. K., & Edwards, C. J. (2010) · Rheumatology · doi:10.1093/rheumatology/kep366 · Cited by 357
Shea, B., Swinden, M. V., Tanjong Ghogomu, E., Ortiz, Z., Katchamart, W., Rader, T., Bombardier, C., Wells, G. A., & Tugwell, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000951.pub2 · Cited by 347
Methotrexate in Rheumatoid Arthritis
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-418 · Cited by 345
Koźmiński, P., Halik, P. K., Chesori, R., & Gniazdowska, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103483 · Cited by 326
ANDERSEN, P. A., WEST, S. G., O'DELL, J. R., VIA, C. S., CLAYPOOL, R. G., & KOTZIN, B. L. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-4-489 · Cited by 331
Visser, K., & van der Heijde, D. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092668 · Cited by 328
Mechanisms, impact and management of pain in rheumatoid arthritis
Walsh, D. A., & McWilliams, D. F. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.64 · Cited by 308
Mladenovic, V., Domljan, Z., Rozman, B., Jajic, I., Mihajlovic, D., Dordevic, J., Popovic, M., Dimitrijevic, M., Zivkovic, M., Campion, G., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381111 · Cited by 303
Paulus, H. E., Egger, M. J., Ward, J. R., & James Williams, H. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330403 · Cited by 285
Self-citationPancytopenia secondary to methotrexate therapy in rheumatoid arthritis
Gutierrez‐Ureña, S., Molina, J. F., García, C. O., Cuéllar, M. L., & Espinoza, L. R. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390214 · Cited by 279
Methotrexate for treating rheumatoid arthritis
Lopez-Olivo, M. A., Siddhanamatha, H. R., Shea, B., Tugwell, P., Wells, G. A., & Suarez-Almazor, M. E. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000957.pub2 · Cited by 277
Methotrexate therapy for chronic noninfectious uveitis
Samson, C. M., Waheed, N., Baltatzis, S., & Foster, C. S. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00576-0 · Cited by 250
Gamma linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial
Zurier, R. B., Rossetti, R. G., Jacobson, E. W., Demarco, D. M., Liu, N. Y., Temming, J. E., White, B. M., & Laposata, M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391106 · Cited by 217
Mitogen-Activated Protein Kinases as Therapeutic Targets for Rheumatoid Arthritis
Paunovic, V., & Harnett, M. M. (2013) · Drugs · doi:10.1007/s40265-013-0014-6 · Cited by 61
Production of novel bioactive compounds by enzymes, and their application to food
Kometani, T. (2010) · Pure and Applied Chemistry · doi:10.1351/pac-con-09-02-05 · Cited by 7
Metadata
- Authors
- Williams, H. J., Willkens, R. F., Samuelson, C. O., Alarcón, G. S., Guttadauria, M., Yarboro, C., Polisson, R. P., Weiner, S. R., Luggen, M. E., Billingsley, L. M., Dahl, S. L., Egger, M. J., Reading, J. C., & Ward, J. R.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 721-730
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2054888624
- Cited by
- 462
- References
- 28
- FWCI
- 19.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.